产品介绍
| 产品名称 Anti-IRAK-1抗体[EPR26375-90] (BSA and Azide free) 参阅全部 IRAK-1 一抗 描述 兔单克隆抗体[EPR26375-90] to IRAK-1 - BSA and Azide free 宿主 Rabbit 经测试应用 适用于: IHC-P, WBmore details 不适用于: Flow Cyt (Intra),ICC/IF or IP 种属反应性 与反应: Human 不与反应: Mouse, Rat 免疫原 Recombinant fragment. This information is proprietary to Abcam and/or its suppliers. 阳性对照 WB: Whole cell lysates: Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell line), HeLa (human cervical adenocarcinoma epithelial cell); human: tonsil tissue lysate, hypothalamus tissue lysate. IHC-P: Human: colon carcinoma tissue, lung cancer and adjacent tissue, wild-type HAP1 (Human chronic myelogenous leukemia near-haploid cell) cell pellet. 常规说明 ab302555 is a carrier-free version of ab302554. ab302554 does not react in: WB with mouse; IHC-P with mouse and rat; ICC, intracellular flow cytometry and immunoprecipitation with human and mouse species. Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free production For more information see here. Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents. |